SAB Biotherapeutics (SABS) Times Interest Earned: 2021-2025
Historic Times Interest Earned for SAB Biotherapeutics (SABS) over the last 5 years, with Sep 2025 value amounting to -$292.87.
- SAB Biotherapeutics' Times Interest Earned fell 102.08% to -$292.87 in Q3 2025 from the same period last year, while for Sep 2025 it was -$174.11, marking a year-over-year decrease of 9.42%. This contributed to the annual value of -$134.77 for FY2024, which is 11.60% down from last year.
- As of Q3 2025, SAB Biotherapeutics' Times Interest Earned stood at -$292.87, which was down 93.64% from -$151.25 recorded in Q2 2025.
- SAB Biotherapeutics' 5-year Times Interest Earned high stood at $10.82 for Q1 2021, and its period low was -$292.87 during Q3 2025.
- For the 3-year period, SAB Biotherapeutics' Times Interest Earned averaged around -$148.06, with its median value being -$144.92 (2024).
- Per our database at Business Quant, SAB Biotherapeutics' Times Interest Earned tumbled by 960.35% in 2022 and then surged by 41.73% in 2024.
- Over the past 5 years, SAB Biotherapeutics' Times Interest Earned (Quarterly) stood at -$110.81 in 2021, then rose by 19.12% to -$89.62 in 2022, then plummeted by 170.40% to -$242.35 in 2023, then skyrocketed by 41.73% to -$141.22 in 2024, then slumped by 102.08% to -$292.87 in 2025.
- Its last three reported values are -$292.87 in Q3 2025, -$151.25 for Q2 2025, and -$154.85 during Q1 2025.